SCHEMBL291415

SCHEMBL291415

CC(C)(O)CCC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
ALDH1A1 P00352 1/20 0.43
SIGMAR1 Q99720 3/20 0.39
HPGD P15428 1/20 0.36
METAP1 P53582 1/20 0.35
EPHX1 P07099 2/20 0.34
HSD11B1 P28845 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28139313 1.00 CYP1A2 (0.46) CYP1A2ALDH1A1SIGMAR1HPGDMETAP1
SCHEMBL5156250 0.97 ALDH1A1 (0.45) CYP1A2ALDH1A1SIGMAR1HPGDMETAP1
Isopropyl Alcohol SCHEMBL13280202 0.91 CYP1A2 (0.40) CYP1A2ALDH1A1SIGMAR1METAP1
SCHEMBL14684528 0.87
SCHEMBL5320353 0.86 CYP1A2 (0.54) CYP1A2ALDH1A1SIGMAR1HPGDEPHX1
Hydrochloric Acid SCHEMBL10996967 0.82 ALDH1A1 (0.45) ALDH1A1
SCHEMBL15757703 0.79 CYP1A2 (0.46) CYP1A2SIGMAR1HPGDMETAP1EPHX1
SCHEMBL22484358 0.79 CYP1A2 (0.50) CYP1A2SIGMAR1HPGDMETAP1EPHX1
SCHEMBL11355859 0.78 ALDH1A1 (0.41) ALDH1A1
SCHEMBL11316028 0.78 ALDH1A1 (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US claimed
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
EP-4695016-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2026-02-18 EP claimed
US-RE50800-E1 Pro-fragrance compounds FIRMENICH SA (CH) 2026-02-17 US claimed
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol GLYCOSCIENCE, S.L. (ES) 2025-12-30 US claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
EP-4555060-A1 LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT The Procter & Gamble Company (US) 2025-05-21 EP claimed
CN-115427421-B 3' -Ketoglycoside compounds for slow release of volatile alcohols 格莱克科学有限公司 2025-04-01 CN claimed
EP-4519404-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN Firmenich SA (CH) 2025-03-12 EP claimed
WO-2010146556-A2 MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE TO COUNTERACT SWEAT MALODOR FIRMENICH SA (CH) 2010-12-23 WO claimed
WO-2010132531-A2 PERFUME SYSTEMS THE PROCTER & GAMBLE COMPANY (US) 2010-11-18 WO claimed
US-20100287710-A1 PERFUME SYSTEMS THE PROCTER & GAMBLE COMPANY 2010-11-18 US claimed
EP-1226113-B1 ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS FIRMENICH & CIE (CH) 2005-11-09 EP claimed
US-6939835-B2 Cyclic compounds and their use as precursors of fragrant alcohols FIRMENICH SA (CH) 2005-09-06 US claimed
US-5726345-A Process for perfuming textiles FIRMENICH S.A. (CH) 1998-03-10 US claimed
US-5649979-A LAUNDERING IN PRESENCE OF ESTER COMPOUND WHICH RELEASES FRAGRANT ALCOHOL, ALDEHYDE OR KETONE FIRMENICH S.A. (CH) 1997-07-22 US claimed
EP-0180885-B1 USE OF A CYCLOALIPHATIC CARBINOL AS A PERFUMING INGREDIENT FIRMENICH SA (CH) 1989-02-15 EP claimed
US-4701278-A ORGANOLEPTIC FIRMENICH SA (CH) 1987-10-20 US claimed
EP-0180885-A2 Use of a cycloaliphatic carbinol as a perfuming ingredient FIRMENICH SA (CH) 1986-05-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 CYP1A2 3106/4885ALDH1A1 2581/4885SIGMAR1 2941/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 CYP1A2 234/4885ALDH1A1 205/4885SIGMAR1 324/4885
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol EBP, MGAT1, MGAT3 CYP1A2 1628/4885ALDH1A1 952/4885SIGMAR1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.